Search results
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity,...
Benzinga via Yahoo Finance· 5 days agoThursday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the SUPERNOVA Phase 3 COVID-...
AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patients
Reuters via AOL· 6 days agoThe long-acting antibody therapy called sipavibart showed a "statistically significant reduction" in...
J. Jill approves first quarterly dividend - The Boston Globe
The Boston Globe· 5 days agoThe European Union opened investigations Thursday into Facebook and Instagram over suspicions that...
Covaxin shows excellent safety track record: Bharat Biotech on study citing risks
Investing.com· 6 days agoCovaxin shows excellent safety track record: Bharat Biotech on study citing risks